Press Releases on March 8, 2021 - EIN Presswire - Press Release Distribution Service

Published on March 8, 2021 - 13:00 GMT

Northern California National Bank Announces Agreement with Investors Seeking to Acquire Its Shares Through Tender Offer

CHICO, Calif., March 08, 2021 (GLOBE NEWSWIRE) -- Northern California National Bank (“NorCal” or the “Bank”) announced today the signing of an agreement pursuant to which investors will seek to acquire 100% of the shares of NorCal through a tender offer to …

Distribution channels: Banking, Finance & Investment Industry, Media, Advertising & PR ...

Published on March 8, 2021 - 13:00 GMT

Vivos Therapeutics Announces the Opening of the First Pneusomnia Integrated Medical-Dental Sleep Center

HIGHLANDS RANCH, Colo., March 08, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“the Company”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on March 8, 2021 - 13:00 GMT

Synaptics Incorporated Announces Offering of $400 Million in Senior Unsecured Notes Due 2029

SAN JOSE, Calif., March 08, 2021 (GLOBE NEWSWIRE) -- Synaptics Incorporated (Nasdaq: SYNA) (the “Company” or “Synaptics”) today announced that it intends to offer, subject to market and other conditions, $400 million aggregate principal amount of senior …

Distribution channels: Banking, Finance & Investment Industry, Technology ...

Published on March 8, 2021 - 13:00 GMT

BrainsWay to Present at the Oppenheimer 31st Annual Healthcare Conference

CRESSKILL, N.J. and JERUSALEM, March 08, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive treatment of brain disorders, today announced that Christopher von Jako, …

Distribution channels:

Published on March 8, 2021 - 13:00 GMT

PLBY Group to Participate in the 33rd Annual Roth Capital Partners Investor Conference

LOS ANGELES, March 08, 2021 (GLOBE NEWSWIRE) -- PLBY Group, Inc. (Nasdaq: PLBY) (the “Company”), a leading pleasure and leisure lifestyle company and owner of Playboy, one of the most recognizable and iconic brands in the world, today announced that the …

Distribution channels: Book Publishing Industry, Culture, Society & Lifestyle ...

Published on March 8, 2021 - 13:00 GMT

OncoImmunology Publishes Pre-clinical Research Showing Galectin Therapeutics’ Belapectin Galectin-3 Inhibitor Reduces Tumor ...

NORCROSS, Ga., March 08, 2021 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that a paper published in the peer-reviewed journal OncoImmunology demonstrates …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on March 8, 2021 - 13:00 GMT

Aligos Therapeutics Presents Nonclinical Data for its COVID-19 Therapeutic in Development at the 2021 Conference on Retroviruses ...

SOUTH SAN FRANCISCO, Calif., March 08, 2021 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in viral and liver diseases, today …

Distribution channels:

Published on March 8, 2021 - 13:00 GMT

Spectral Medical Announces the Appointment of Chris Seto to CEO

Dr. Paul Walker will remain on the Board of Directors focusing on the seamless transition of management and on ensuring continuity of the Tigris Trial TORONTO, March 08, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on March 8, 2021 - 13:00 GMT

Caladrius Biosciences Announces Orphan Drug Designation for CLBS12 for the Treatment of Buerger’s Disease

BASKING RIDGE, N.J., March 08, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease, …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on March 8, 2021 - 13:00 GMT

AnaptysBio Reports Imsidolimab POPLAR Phase 2 Clinical Trial in Moderate-to-Severe Palmoplantar Pustulosis (PPP) Did Not Meet ...

Imsidolimab treatment did not demonstrate statistically significant improvement over placebo in PPPASI change from baseline at week 16 primary endpoint Imsidolimab was generally well tolerated and no serious or severe adverse events were reported in the …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on March 8, 2021 - 13:00 GMT

iCAD Announces Closing of $25.0 Million Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase ...

NASHUA, N.H., March 08, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (the “Company”, NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the closing on March 5, 2021 of its previously …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on March 8, 2021 - 13:00 GMT

GameStop Provides Corporate Governance Update

GRAPEVINE, Texas, March 08, 2021 (GLOBE NEWSWIRE) -- GameStop Corp. (NYSE: GME) (“GameStop” or the “Company”) today announced that its Board of Directors (the “Board”) has formed a Strategic Planning and Capital Allocation Committee (the “Committee”) to …

Distribution channels: Electronics Industry, Media, Advertising & PR ...

Published on March 8, 2021 - 13:00 GMT

AzurRx BioPharma Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

DELRAY BEACH, Fla., March 08, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal ( …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on March 8, 2021 - 13:00 GMT

Contango Announces Schedule for Fourth Quarter 2020 Earnings Release and Conference Call

FORT WORTH, Texas, March 08, 2021 (GLOBE NEWSWIRE) -- Contango Oil & Gas Company (NYSE American: MCF) (“Contango” or the “Company”) announced today that it plans to issue its fourth quarter 2020 earnings release before market open on Wednesday, March …

Distribution channels:

Published on March 8, 2021 - 13:00 GMT

Shell Midstream Partners, L.P. Tax Packages Available

Houston, March 08, 2021 (GLOBE NEWSWIRE) -- Shell Midstream Partners, L.P. (NYSE: SHLX) has announced that the Partnership’s 2020 investor K-1 tax packages are now available on its website, http://www.shellmidstreampartners.com. Investors may access the …

Distribution channels: Banking, Finance & Investment Industry, Shipping, Storage & Logistics ...

Published on March 8, 2021 - 13:00 GMT

Soleno Therapeutics Provides Regulatory Update on DCCR for the Treatment of Prader-Willi Syndrome

REDWOOD CITY, Calif., March 08, 2021 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today provided an update following …

Distribution channels: Science, Technology ...

Published on March 8, 2021 - 13:00 GMT

Gibson Energy Recognized as Sustainability Leader and Announces Establishment of Expanded Sustainability and ESG Targets

CALGARY, Alberta, March 08, 2021 (GLOBE NEWSWIRE) -- Gibson Energy Inc. is pleased to announce today the establishment of expanded Sustainability and Environmental, Social and Governance (“ESG”) targets as well as its intention to publish reporting during …

Distribution channels: Energy Industry, Media, Advertising & PR ...

Published on March 8, 2021 - 13:00 GMT

Talis Provides Update on Regulatory Pathway for Emergency Use Authorization (EUA) of its Talis One™ COVID-19 Test

MENLO PARK, Calif., March 08, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to developing innovative molecular diagnostic tests for infectious diseases at the point-of-care, today announced that it has withdrawn …

Distribution channels: Media, Advertising & PR, Technology ...

Published on March 8, 2021 - 13:00 GMT

Chembio Diagnostics Appoints Industry Leader David Bespalko to its Board of Directors

HAUPPAUGE, N.Y., March 08, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced the appointment of David Bespalko to the Company’s Board of Directors, …

Distribution channels: Companies ...

Published on March 8, 2021 - 13:00 GMT

BetterLife Enters Research Agreement with Carleton University for TD-0148A Depression Studies

VANCOUVER, March 08, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development and commercialization of cutting-edge treatments in mental …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...